curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 11,660
-40 (-0.34%)
At close: Aug 11, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 248.83 billion as of August 12, 2026. Its market cap has increased by 312.11% in one year.
Market Cap
248.83B
Enterprise Value
240.52B
Revenue
1.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,660.00
ChartMarket Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 248.83B, a decrease of -39.21%. That is a compound annual growth rate of -9.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 248.40B | 65.83% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 308.76B |
| IMBiologics | 271.21B |
| IntoCell | 270.40B |
| S.Biomedics | 239.03B |
| Kangstem Biotech | 224.79B |
| Kanaph Therapeutics | 185.00B |
| NIBEC | 175.75B |
| Genome & Company | 164.80B |